Cardinal Health, Inc. and Ovation Pharmaceuticals, Inc. received an approval letter from the FDA for Cardinal Health’s new sterile facility in North Raleigh, NC to manufacture Panhemati, an Ovation biologic therapy used to treat acute porphyria, a rare genetic disorder. The new facility currently has 82 employees and is expected to grow to 200 jobs for the Raleigh area when it reaches full capacity. Jeffrey S. Aronin, president and chief executive officer of Ovation Pharmaceuticals said, “We...